</span><b><span style="font-family:Verdana;">Introduction:</span></b><span style="font-family:Verdana;"></b> Chemotherapy is used to combat tuberculosis, a...</span><b><span style="font-family:Verdana;">Introduction:</span></b><span style="font-family:Verdana;"></b> Chemotherapy is used to combat tuberculosis, and other microbial infections. Unfortunately, resistance has been reported to a vast majority of currently use drugs.</span></span><span style="font-family:""> </span><span style="font-family:Verdana;">The objective of this study was to search</span><span style="font-family:""><span style="font-family:Verdana;"> for new therapies from plant products for the sustainable management of tuberculosis and <i></span><i><span style="font-family:Verdana;">S. aureus</span></i><span style="font-family:Verdana;"></i></span><i> </i><span style="font-family:Verdana;">infections. <b></span><b><span style="font-family:Verdana;">Materials and Methods:</span></b><span style="font-family:Verdana;"></b> Crude extracts were obtained by sequential maceration of dry powdered plant material in three solvents;hexane, dichloromethane and methanol. Phytochemical screening to identify active constituents in the crude extracts was done by conventional methods. The antimycobacterial and antimicrobial activity on <i></span><i><span style="font-family:Verdana;">M. tuberculosis</span></i><span style="font-family:Verdana;"></i> control strain H37Ra and a clinical isolate of <i></span><i><span style="font-family:Verdana;">S. aureus</span></i><span style="font-family:Verdana;"></i> respectively, was evaluated at eight different concentrations using the microplatealamar blue assay. Cytotoxicity of the active extracts was evaluated on monkey kidney epithelial cells and assessed using the MTT/formazan assay. <b></span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"></b> Twelve crude extracts were obtained, the hexane extract of <i></span><i><span style="font-family:Verdana;">Sanseviera</span></i></span><i><span style="font-family:""> </span></i><i><span style="font-family:Verdana;">liberica</span></i><span style="font-family:""><span style="font-family:Verdana;"></i> rhizomes (P3rH) showed antimycobacterial activity with a minimum inhibitory concentration (MIC) of 1 mg/mL. The hexane and methanol extracts of <i></span><i><span style="font-family:Verdana;">Emilia coccinea</span></i><span style="font-family:Verdana;"></i>, P2H and P2M respectively, showed antimicrobial activity with MICs of 500 μg/mL and 1000 μg/mL respectively. P2M and P2H had selectivity indices of respectively, 0.1046 and 0.2336. <b></span><b><span style="font-family:Verdana;">Conclusion:</span></b><span style="font-family:Verdana;"></b></span><b> </b><span style="font-family:Verdana;">This study validates the use of <i></span><i><span style="font-family:Verdana;">S. liberica</span></i><span style="font-family:Verdana;"></i> and <i></span><i><span style="font-family:Verdana;">E. coccinea</span></i><span style="font-family:Verdana;"></i> for the traditional management of tuberculosis and <i></span><i><span style="font-family:Verdana;">S. aureus</span></i><span style="font-family:Verdana;"></i> infections, respectively. Furthermore, it provides a base for the purification of the active extracts and generation of leads in the search of alternative drugs for the management of these microbial infections.展开更多
文摘</span><b><span style="font-family:Verdana;">Introduction:</span></b><span style="font-family:Verdana;"></b> Chemotherapy is used to combat tuberculosis, and other microbial infections. Unfortunately, resistance has been reported to a vast majority of currently use drugs.</span></span><span style="font-family:""> </span><span style="font-family:Verdana;">The objective of this study was to search</span><span style="font-family:""><span style="font-family:Verdana;"> for new therapies from plant products for the sustainable management of tuberculosis and <i></span><i><span style="font-family:Verdana;">S. aureus</span></i><span style="font-family:Verdana;"></i></span><i> </i><span style="font-family:Verdana;">infections. <b></span><b><span style="font-family:Verdana;">Materials and Methods:</span></b><span style="font-family:Verdana;"></b> Crude extracts were obtained by sequential maceration of dry powdered plant material in three solvents;hexane, dichloromethane and methanol. Phytochemical screening to identify active constituents in the crude extracts was done by conventional methods. The antimycobacterial and antimicrobial activity on <i></span><i><span style="font-family:Verdana;">M. tuberculosis</span></i><span style="font-family:Verdana;"></i> control strain H37Ra and a clinical isolate of <i></span><i><span style="font-family:Verdana;">S. aureus</span></i><span style="font-family:Verdana;"></i> respectively, was evaluated at eight different concentrations using the microplatealamar blue assay. Cytotoxicity of the active extracts was evaluated on monkey kidney epithelial cells and assessed using the MTT/formazan assay. <b></span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"></b> Twelve crude extracts were obtained, the hexane extract of <i></span><i><span style="font-family:Verdana;">Sanseviera</span></i></span><i><span style="font-family:""> </span></i><i><span style="font-family:Verdana;">liberica</span></i><span style="font-family:""><span style="font-family:Verdana;"></i> rhizomes (P3rH) showed antimycobacterial activity with a minimum inhibitory concentration (MIC) of 1 mg/mL. The hexane and methanol extracts of <i></span><i><span style="font-family:Verdana;">Emilia coccinea</span></i><span style="font-family:Verdana;"></i>, P2H and P2M respectively, showed antimicrobial activity with MICs of 500 μg/mL and 1000 μg/mL respectively. P2M and P2H had selectivity indices of respectively, 0.1046 and 0.2336. <b></span><b><span style="font-family:Verdana;">Conclusion:</span></b><span style="font-family:Verdana;"></b></span><b> </b><span style="font-family:Verdana;">This study validates the use of <i></span><i><span style="font-family:Verdana;">S. liberica</span></i><span style="font-family:Verdana;"></i> and <i></span><i><span style="font-family:Verdana;">E. coccinea</span></i><span style="font-family:Verdana;"></i> for the traditional management of tuberculosis and <i></span><i><span style="font-family:Verdana;">S. aureus</span></i><span style="font-family:Verdana;"></i> infections, respectively. Furthermore, it provides a base for the purification of the active extracts and generation of leads in the search of alternative drugs for the management of these microbial infections.